HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Pinebridge Investments L.P.

Pinebridge Investments L.P. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,849 shares of the company’s stock after purchasing an additional 26,836 shares during the quarter. Pinebridge Investments L.P.’s holdings in HCA Healthcare were worth $28,769,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of HCA. Barclays PLC lifted its position in shares of HCA Healthcare by 22.3% during the third quarter. Barclays PLC now owns 571,975 shares of the company’s stock worth $232,467,000 after purchasing an additional 104,409 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of HCA Healthcare during the third quarter valued at about $688,000. Franklin Resources Inc. lifted its stake in shares of HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after acquiring an additional 174,946 shares in the last quarter. American Trust acquired a new stake in HCA Healthcare during the 3rd quarter valued at approximately $372,000. Finally, Oddo BHF Asset Management Sas acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $3,278,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on HCA shares. Bank of America cut their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Guggenheim started coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating for the company. Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Finally, StockNews.com cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, April 9th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $381.67.

HCA Healthcare Trading Up 2.2 %

Shares of HCA stock opened at $324.64 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market capitalization of $79.93 billion, a PE ratio of 14.78, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The stock has a fifty day moving average of $328.71 and a two-hundred day moving average of $333.13. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the business earned $5.90 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.89%. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.